Chiron Investment Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$9.29M |
| 2 |
Merck
MRK
|
+$6.99M |
| 3 |
Intercontinental Exchange
ICE
|
+$6.08M |
| 4 |
Trip.com Group
TCOM
|
+$6.01M |
| 5 |
Colgate-Palmolive
CL
|
+$4.31M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
IBM
IBM
|
+$7.11M |
| 2 |
MSCI
MSCI
|
+$6.6M |
| 3 |
Constellation Brands
STZ
|
+$5.95M |
| 4 |
Mercado Libre
MELI
|
+$5.83M |
| 5 |
Salesforce
CRM
|
+$5.71M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.41% |
| 2 | Financials | 15.46% |
| 3 | Consumer Discretionary | 12.71% |
| 4 | Healthcare | 11.48% |
| 5 | Materials | 10.33% |
Similar funds
Chiron Investment Management's Q2 2024 Portfolio in Review
As of Q2 2024, Chiron Investment Management held 121 positions worth $255M, up 10% from $231M the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Chiron Investment Management deployed $8.32M of net new capital in Q2 2024, opening 18 new positions and adding to 36 existing holdings. Its largest new stake was Merck: 54,265 shares worth $6.72M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 29% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Mercado Libre, an estimated $5.83M trimmed.
- Chiron Investment Management's largest Q2 2024 buy was Merck: 54,265 shares worth $6.72M.
- Chiron Investment Management added most to Apple in Q2 2024, an estimated $9.29M increase.
- Chiron Investment Management's biggest Q2 2024 reduction was Mercado Libre, cutting an estimated $5.83M.
- Chiron Investment Management fully exited IBM in Q2 2024, selling an estimated $7.11M.
- Chiron Investment Management's ten largest holdings make up 46% of its $255M portfolio in Q2 2024.
- Chiron Investment Management opened 18 new positions and closed 50 in Q2 2024.
- Chiron Investment Management's portfolio value rose 10% quarter-over-quarter to $255M.
Based on Chiron Investment Management's 13F filing for Q2 2024, filed 13 Aug 2024.